Mineralys Therapeutics, Inc.
SEC CIK 1933414 · MLYS · last insider filing 2026-06-30
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Congleton Jon | Director · Chief Executive Officer | filed 2023 - 2026 |
| Karydas Daphne | Director | filed 2023 - 2026 |
| RA Capital Healthcare Fund LP | Director | filed 2023 - 2026 |
| RA Capital Management, LLC | Director | filed 2023 - 2026 |
| Kolchinsky Peter | Director | filed 2023 - 2026 |
| Shah Rajeev M. | Director | filed 2023 - 2026 |
| RA Capital Nexus Fund III, L.P. | Director | filed 2023 - 2026 |
| Akkaraju Srinivas | Director | filed 2023 - 2026 |
| Sblendorio Glenn | Director | filed 2023 - 2026 |
| Dirocco Derek | Director | filed 2023 - 2026 |
| Slingsby Brian Taylor | Director | filed 2023 - 2026 |
| Gold Alexander M | Director | filed 2024 - 2026 |
| Litzka Olivier | Director | filed 2023 - 2024 |
| Takahashi Takeshi | Director | filed 2023 - 2023 |
| Asam Alexander | Director | filed 2023 - 2023 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Warren Eric | Chief Commercial Officer | filed 2026 - 2026 |
| Rodman David Malcom | Chief Medical Officer | filed 2023 - 2026 |
| Levy Adam Scott | CFO, Chief Bus. Off. and Secy. | filed 2023 - 2026 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.